NO985227L - Alkylaminobenzothiazol og -benzoksazol - derivater - Google Patents

Alkylaminobenzothiazol og -benzoksazol - derivater

Info

Publication number
NO985227L
NO985227L NO985227A NO985227A NO985227L NO 985227 L NO985227 L NO 985227L NO 985227 A NO985227 A NO 985227A NO 985227 A NO985227 A NO 985227A NO 985227 L NO985227 L NO 985227L
Authority
NO
Norway
Prior art keywords
alkylaminobenzothiazole
benzoxazole derivatives
benzoxazole
derivatives
Prior art date
Application number
NO985227A
Other languages
English (en)
Other versions
NO311027B1 (no
NO985227D0 (no
Inventor
Ludo Edmond Josephine Kennis
Josephus Carolus Mertens
Serge Maria Aloysius Pieters
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO985227D0 publication Critical patent/NO985227D0/no
Publication of NO985227L publication Critical patent/NO985227L/no
Publication of NO311027B1 publication Critical patent/NO311027B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO19985227A 1996-05-10 1998-11-09 Alkylaminobenzotiazol og -benzoksazolderivater NO311027B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201282 1996-05-10
PCT/EP1997/002505 WO1997043271A1 (en) 1996-05-10 1997-05-02 Alkylaminobenzothiazole and -benzoxazole derivatives

Publications (3)

Publication Number Publication Date
NO985227D0 NO985227D0 (no) 1998-11-09
NO985227L true NO985227L (no) 1999-01-11
NO311027B1 NO311027B1 (no) 2001-10-01

Family

ID=8223970

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985227A NO311027B1 (no) 1996-05-10 1998-11-09 Alkylaminobenzotiazol og -benzoksazolderivater

Country Status (28)

Country Link
US (2) US6103725A (no)
EP (2) EP1325917B1 (no)
JP (1) JP3237759B2 (no)
KR (1) KR100330699B1 (no)
CN (1) CN1074766C (no)
AR (1) AR007079A1 (no)
AT (2) ATE350373T1 (no)
AU (1) AU710175B2 (no)
BG (1) BG64097B1 (no)
BR (1) BR9709065A (no)
CA (1) CA2253453C (no)
CZ (1) CZ295639B6 (no)
DE (2) DE69730962T2 (no)
EA (1) EA001360B1 (no)
EE (1) EE03563B1 (no)
ES (2) ES2279923T3 (no)
HU (1) HUP9902993A3 (no)
ID (1) ID16889A (no)
IL (1) IL126968A0 (no)
MY (1) MY117852A (no)
NO (1) NO311027B1 (no)
NZ (1) NZ332309A (no)
PL (1) PL190721B1 (no)
SK (1) SK282919B6 (no)
TR (1) TR199802253T2 (no)
TW (1) TW593290B (no)
WO (1) WO1997043271A1 (no)
ZA (1) ZA974053B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293804B1 (it) 1997-08-01 1999-03-10 Recordati Chem Pharm Diarilalchilpiperazine attive sulle basse vie urinarie
US6281216B1 (en) * 1998-02-09 2001-08-28 Duphar International Research B.V. 2-aminoquinoline derivatives having d4-agonistic activity
EP0982030A3 (en) 1998-08-17 2000-05-10 Pfizer Products Inc. 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
AU6280199A (en) * 1998-09-30 2000-04-17 Neurogen Corporation 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
US6284759B1 (en) 1998-09-30 2001-09-04 Neurogen Corporation 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
WO2001000604A1 (fr) * 1999-06-30 2001-01-04 Santen Pharmaceutical Co., Ltd. Ligand de liaison avec le recepteur sigma-1 du cerveau
AU2001249679A1 (en) 2000-03-31 2001-10-15 Ortho-Mcneil Pharmaceutical, Inc. Phenyl-substituted imidazopyridines
AU2001251083A1 (en) 2000-03-31 2001-10-15 Ortho-Mcneil Pharmaceutical, Inc. Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists
GB0203299D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel compounds
WO2004022060A2 (en) 2002-09-06 2004-03-18 Janssen Pharmaceutica, N.V. (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
US9017724B2 (en) 2004-02-24 2015-04-28 The General Hospital Corporation Catalytic radiofluorination
US8257680B1 (en) 2004-02-24 2012-09-04 The General Hospital Corporation Catalytic radiofluorination
EP2388017B1 (en) * 2004-02-24 2014-12-24 The General Hospital Corporation Catalytic radiofluorination
FR2877005A1 (fr) * 2004-10-22 2006-04-28 Bioprojet Soc Civ Ile Nouveaux derives d'arylpiperazine
US7731940B2 (en) 2006-01-25 2010-06-08 The Regents Of The University Of California Compositions and methods related to serotonin 5-HT1A receptors
EP3231804B1 (en) 2008-03-21 2021-03-03 The General Hospital Corporation Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders
KR20190040502A (ko) * 2016-08-26 2019-04-18 브리스톨-마이어스 스큅 컴퍼니 인돌아민 2,3-디옥시게나제의 억제제 및 그의 사용 방법
PT109740B (pt) 2016-11-14 2020-07-30 Hovione Farmaciencia Sa Processo para a preparação de brometo de umeclidínio
KR102823891B1 (ko) * 2020-01-14 2025-06-20 서울대학교산학협력단 혈관생성 저해 효과를 가지는 n-페닐벤조티아졸-2-아민 화합물 및 그를 포함하는 약제학적 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3480340D1 (en) * 1984-05-22 1989-12-07 Sumitomo Chemical Co Novel radioactive iodospiroperidol and process for its preparation
AU620327B2 (en) * 1987-04-08 1992-02-20 Salutar, Inc. Amyloidosis and alzheimer's disease diagnostic assay and reagents therefor
US4929618A (en) * 1988-03-25 1990-05-29 Ube Industries, Ltd. Piperdine and piperazine derivatives, and antihistaminic pharmaceutical compositions containing the same
FR2656609B1 (fr) * 1989-12-28 1992-03-27 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
US5731438A (en) * 1996-08-01 1998-03-24 Isis Pharmaceuticals, Inc. N-(aminoalkyl)-and/or N-(amidoalkyl)-dinitrogen heterocycles

Also Published As

Publication number Publication date
CN1218461A (zh) 1999-06-02
NZ332309A (en) 1999-08-30
TR199802253T2 (xx) 1999-02-22
ES2230605T3 (es) 2005-05-01
NO311027B1 (no) 2001-10-01
US6103725A (en) 2000-08-15
EA001360B1 (ru) 2001-02-26
ATE277917T1 (de) 2004-10-15
BG102819A (en) 1999-08-31
AR007079A1 (es) 1999-10-13
EE03563B1 (et) 2001-12-17
HK1018457A1 (en) 1999-12-24
SK282919B6 (sk) 2003-01-09
EA199801000A1 (ru) 1999-04-29
SK153298A3 (en) 1999-03-12
DE69737217D1 (de) 2007-02-15
BG64097B1 (bg) 2003-12-31
ES2279923T3 (es) 2007-09-01
BR9709065A (pt) 1999-08-03
JP3237759B2 (ja) 2001-12-10
CZ295639B6 (cs) 2005-09-14
HUP9902993A2 (hu) 2000-05-28
IL126968A0 (en) 1999-09-22
EP1325917B1 (en) 2007-01-03
NO985227D0 (no) 1998-11-09
ZA974053B (en) 1998-11-09
DE69730962D1 (de) 2004-11-04
US6224849B1 (en) 2001-05-01
CN1074766C (zh) 2001-11-14
ATE350373T1 (de) 2007-01-15
KR100330699B1 (ko) 2002-08-27
ID16889A (id) 1997-11-20
EP1325917A1 (en) 2003-07-09
AU710175B2 (en) 1999-09-16
EP0912533A1 (en) 1999-05-06
DE69730962T2 (de) 2006-03-30
EP0912533B1 (en) 2004-09-29
WO1997043271A1 (en) 1997-11-20
PL329849A1 (en) 1999-04-12
HUP9902993A3 (en) 2002-01-28
TW593290B (en) 2004-06-21
CA2253453C (en) 2007-01-16
AU2956097A (en) 1997-12-05
CZ355398A3 (cs) 1999-02-17
HK1057044A1 (en) 2004-03-12
MY117852A (en) 2004-08-30
KR20000005227A (ko) 2000-01-25
PL190721B1 (pl) 2005-12-30
EE9800378A (et) 1999-04-15
CA2253453A1 (en) 1997-11-20
DE69737217T2 (de) 2007-11-08
JP2000503667A (ja) 2000-03-28

Similar Documents

Publication Publication Date Title
ATE323682T1 (de) Aryl-pyrimidin-derivate
DK0891332T3 (da) 6-phenylpyridyl-2-aminderivater
FI954681A7 (fi) Sykloalkano-indoli- ja azaindolijohdannaisia
FR11C0020I2 (fr) Dérives difluoroprostaglandines et leur application
FI954829L (fi) Aroyylipiperidiinijohdannaiset
NO952854D0 (no) 1-arylpyrimidin-derivater
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
NO981946D0 (no) Imidazoquinazolin-derivater
EE9800219A (xx) Uued 19-nor-pregneeni derivaadid
NO985227L (no) Alkylaminobenzothiazol og -benzoksazol - derivater
BR9506832A (pt) N-pirazolilanilinas e n-pirazolilaminopiridinas
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
DE69430587D1 (de) Pyrimidin-acyclonukleosid-derivate
FI971227L (fi) Pyramidinyylipyratsolijohdannaisia
IS5026A (is) 2-metoxýfenýlpíperasín afleiður
DK0826679T3 (da) Naphthylforbindelser og -præparater
DE69527786D1 (de) Diaminomethyliden-derivate
FI964853L (fi) Deasetoksitaksolijohdannaiset
DE59509209D1 (de) Diphenyloxazolin-derivate
DE69510792D1 (de) Naphtochinonderivate
FI955026A7 (fi) Alkyyli-5-metyylisulfonyylibentsoyyliguanidiinijohdannaisia
FI965181A7 (fi) Polyalkoholi-peptidijohdannaiset
FI963122L (fi) Karbamoyylimetyyliureajohdannaiset
DE59812220D1 (de) Halte- und trageband
BR7603138U (pt) Prática e única